Westfield Capital Management Co. LP Has $73.60 Million Stake in Danaher Corporation $DHR

Westfield Capital Management Co. LP grew its stake in shares of Danaher Corporation (NYSE:DHR) by 6,390.8% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 321,487 shares of the conglomerate’s stock after buying an additional 316,534 shares during the period. Westfield Capital Management Co. LP’s holdings in Danaher were worth $73,595,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in DHR. JPL Wealth Management LLC bought a new stake in Danaher in the third quarter valued at about $25,000. WFA of San Diego LLC bought a new stake in Danaher in the second quarter valued at about $26,000. Elevated Capital Advisors LLC bought a new stake in Danaher in the fourth quarter valued at about $26,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher in the third quarter valued at about $27,000. Finally, Financial Life Planners bought a new stake in Danaher in the third quarter valued at about $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $184.45 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market capitalization of $130.55 billion, a price-to-earnings ratio of 35.68, a price-to-earnings-growth ratio of 2.49 and a beta of 0.81. The company has a 50-day simple moving average of $181.29 and a two-hundred day simple moving average of $206.19.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the firm earned $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analysts Set New Price Targets

A number of analysts recently weighed in on DHR shares. DZ Bank started coverage on shares of Danaher in a research note on Wednesday. They issued a “buy” rating and a $210.00 target price on the stock. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday. The Goldman Sachs Group cut their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Finally, Morgan Stanley lowered their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $235.14.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.